Intouch Group announced the addition of Intouch Market Access as the full-service global agency network’s eighth affiliate to address the ever-evolving needs of clients.

A federal judge on Sept. 24 ruled that a Cincinnati, Ohio-area healthcare provider could require employees to get vaccinated against Covid-19 or risk losing their job, in what appears to be the first ruling of its kind for a private employer in the United States.

Combining medical information (MI) and pharmacovigilance (PV) has been shown to drive an array of positive outcomes, including accelerating adverse event intake, improving healthcare professional and patient communications, intelligently connecting enterprise systems and importantly, driving better patient safety. New innovations in connected technologies are finally making it possible to combine elements of these functions in a thoughtful way. However, the change from legacy processes and mindset will be significant and driving employee adoption to see the benefit of these investments will require careful change management. IQVIA’s Annette Williams and Libbie McKenzie explore considerations for leaders looking to combine aspects of their MI and PV functions and how they can effectively roll out this shift to maximize the benefits to their organizations along with patients, providers, and other key stakeholders.

The model for healthcare delivery and treatment was upended by the COVID-19 pandemic, as ordinary Americans have learned to take more control of their own care and treatment, harnessing a new class of technology tools that have given individuals unprecedented clout. But patients and healthcare providers still need to partner together for the best outcomes, according to Jim Weiss, founder and CEO of Real Chemistry.

As meetings with pharmaceutical sales reps migrate online and more patients visit with their healthcare providers via video, digital has set a new norm within life sciences. The sudden shift toward virtual engagement last year laid the groundwork for more efficient exchanges. And it’s now driving reps to continue engaging with healthcare professionals (HCPs) remotely, even as in-person access returns beyond the pandemic. 

Moderna Inc. filed for U.S. authorization to use the company’s Covid-19 vaccine in adolescents aged 12 through 17, potentially offering healthcare providers and pediatricians an easier-to-store shot ahead of the return-to-school season in the fall.

In a $7 billion transaction, San Francisco-based Datavant is merging with data network company Ciox Health to create the nation’s largest “neutral and secure health data ecosystem.”

As we continue to sift through the barrage of information regarding survival rates, resurgence, vaccines, and secondary illnesses, COVID-19 and its economic impact continues to be a primary global burden. In the midst of those serious concerns, the health and life sciences (HLS) industry continues its accelerated journey of perpetual assessment and evolution. As the industry emerges from the pandemic effect, leaders are realizing that COVID-19 has provided crucial learnings to their organizations that will benefit the entire industry, according to Astound Commerce’s Tina Wilson.

Dentsu International announced on April 20 the launch of dentsu health, a global solution. Drawing upon the expertise of dentsu’s global network of 2,000 health marketing experts across 85 markets in EMEA, APAC and the Americas, dentsu health is poised to become one of the top global healthcare agencies.

Three major U.S. drug distributors requested the government to expand the Covid-19 vaccine supply chain network as the country strives to immunize its population against the novel coronavirus as quickly as possible.